MedPath

Model-Guided Antipsychotic Dose Reduction in Schizophrenia: A Single-Blind Randomized Controlled Trial

Not Applicable
Conditions
Schizophrenia
Registration Number
JPRN-UMIN000014976
Lead Sponsor
Minamihanno Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Concomitant use of antipsychotic drugs other than quetiapine at 50 mg or less or its chlorpromazine equivalent at bedtime (2) History of treatment with long-acting risperidone within 6 months (3) Active suicidal ideations or past suicide attempts (4) Presence of severe physical condition, mental retardation, or active substance abuse

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath